Biofrontera
BFRI
12 hedge funds and large institutions have $1.05M invested in Biofrontera in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
9% more funds holding
Funds holding: 11 → 12 (+1)
1.63% more ownership
Funds ownership: 21.33% → 22.97% (+1.6%)
37% less capital invested
Capital invested by funds: $1.67M → $1.05M (-$616K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Scotia Capital
Toronto,
Ontario, Canada
|
+$111K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$24.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$13.8K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$11.9K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$116 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$18.8K |
| 2 |
HF
HRT Financial
New York
|
-$16K |
| 3 |
Renaissance Technologies
New York
|
-$16K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RA
1
Rosalind Advisors
Toronto,
Ontario, Canada
| $453K | – | – | – |
|
|
ACM
2
AIGH Capital Management
Baltimore,
Maryland
| $450K | – | – | – |
|
|
SC
3
Scotia Capital
Toronto,
Ontario, Canada
| $108K | +$111K | +80,000 | +200% |
|
|
4
Geode Capital Management
Boston,
Massachusetts
| $15.8K | +$24.2K | +17,542 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $9.42K | +$11.9K | +8,586 | +451% |
|
|
6
UBS Group
Zurich,
Switzerland
| $8.99K | +$13.8K | +10,017 | New |
|
7
BlackRock
New York
| $4.15K | – | – | – |
|
8
Osaic Holdings
Scottsdale,
Arizona
| $518 | – | – | – |
|
|
9
Wells Fargo
San Francisco,
California
| $82 | +$116 | +84 | +1,200% |
|
10
Bank of America
Charlotte,
North Carolina
| $22 | +$33 | +24 | New |
|
11
Morgan Stanley
New York
| $5 | +$8 | +6 | New |
|
|
XT
12
XTX Topco
George Town,
Cayman Islands
| – | -$18.8K | -12,185 | Closed |
|
|
HF
13
HRT Financial
New York
| – | -$16K | -10,639 | Closed |
|
|
14
Renaissance Technologies
New York
| – | -$16K | -10,221 | Closed |
|
BFRI Hedge Fund Activity: Q2 2024 in Review
12 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRI) for Q2 2024, worth a combined $1.05M — down 37% from $1.67M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BFRI positions and 3 closed out — a net gain of 1 holder — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Scotia Capital, adding an estimated $111K. The largest seller was XTX Topco, exiting entirely with an estimated $18.8K sold.
- 12 institutional investors held Biofrontera (BFRI) as of Q2 2024, up from 11 in Q1 2024.
- Funds reported $1.05M of Biofrontera stock for Q2 2024, down 37% quarter-over-quarter.
- 4 funds opened new Biofrontera positions in Q2 2024 and 3 closed out, a net change of +1 holder.
- The largest Biofrontera buyer in Q2 2024 was Scotia Capital, an estimated $111K added.
- The largest Biofrontera seller in Q2 2024 was XTX Topco, an estimated $18.8K sold.
Based on aggregated 13F filings for Q2 2024.